active transport

Active transport is classified into primary and secondary types. Primary active transport directly uses ATP hydrolysis to move substances against their gradient—classic examples include the Na+/K+-ATPase pump (maintains resting membrane potential, pumps 3 Na+ out and 2 K+ in per ATP), the H+/K+-ATPase in gastric parietal cells (mediates acid secretion, target of proton pump inhibitors), and the Ca2+-ATPase (SERCA pump in sarcoplasmic reticulum, important in muscle relaxation). Secondary active transport (cotransport) does not directly use ATP but instead harnesses the energy stored in an ion gradient (often Na+) established by primary active transport pumps. This includes symporters (e.g., SGLT1/2 in intestinal and renal Na+/glucose cotransport, Na+/I- symporter in thyroid) and antiporters (e.g., Na+/H+ exchanger in renal proximal tubule, Na+/Ca2+ exchanger in cardiac myocytes). Clinically, active transport mechanisms are critical drug targets: cardiac glycosides (digoxin) inhibit Na+/K+-ATPase leading to increased intracellular Ca2+ and enhanced contractility; PPIs inhibit H+/K+-ATPase to reduce gastric acid secretion; SGLT2 inhibitors (e.g., empagliflozin) block renal glucose reabsorption for diabetes management. Genetic defects in transporters (e.g., cystinuria due to defective amino acid transporter, Hartnup disease) illustrate the clinical relevance of these systems. Understanding active transport is fundamental to renal physiology (reabsorption/secretion), GI absorption, neuronal signaling (action potential generation via Na+/K+ pump), and pharmacology (drug mechanisms targeting these pumps).